NINDS scientists are seeking persons with neurofibromatosis type 2 (NF2) to participate in a research study to learn about NF2 tumor development and progression.
Study participants will have an evaluation of their NF2-related tumors and how those tumors affect vision, walking, hearing, and balance. All testing—which will include magnetic resonance imaging (MRI)—will be performed on an outpatient basis and will be repeated every 6 months for up to 5 years.
Eligible persons must have a diagnosis of NF2 by established criteria or genetic testing, be 8 to 75 years old, and be able to have MRI scans. Persons who are pregnant, or who have an allergy to MRI contrast may not be eligible.
The study will take place at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. There is no charge for study-related tests. Travel costs may be reimbursed.
For more information, contact the Patient Recruitment Office at 800-411-1222 or email@example.com. Please refer to study number 08-N-0044.